All the economic studies of genomic tests for breast cancer rely on modeling rather than randomized controlled trials or other direct trial data.
Robert D. Lieberthal, PhD
Advertisement
Articles by Robert D. Lieberthal, PhD
Advertisement
Latest Updated Articles
- Economics of Genomic Testing for Women With Breast Cancer
December 23rd 2013
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5